Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ghika

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Revue Medicale Suisse|June 28, 2005
[Is there a treatment for Alzheimer's disease?]S Joray, J Ghika, A von Gunten, et al.
Acta Neurochirurgica|February 14, 2004
Magnetic resonance artifact induced by the electrode Activa 3389: an in vitro and in vivo studyC Pollo, J-G Villemure, F Vingerhoets, et al.
Journal of Neurosurgery|November 17, 1998
Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up reviewJ Ghika, J G Villemure, H Fankhauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Acute reversible myoclonic encephalopathy associated with fluoxetine therapyF Ghika-Schmid, J Ghika, P Vuadens, et al.
Neurology|February 13, 2002
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-upFrançois J G Vingerhoets, J-G Villemure, P Temperli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 1997
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
IEEE Transactions on Bio-Medical Engineering|March 1, 1993
Portable system for quantifying motor abnormalities in Parkinson's diseaseJ Ghika, A W Wiegner, J J Fang, et al.
Neurology|December 15, 2004
Suicide after successful deep brain stimulation for movement disordersP R Burkhard, F J G Vingerhoets, A Berney, et al.
Neurology|May 20, 1998
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1995
Vascular ataxic hemiparesis: a re-evaluationT Moulin, J Bogousslavsky, J L Chopard, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Revue Medicale Suisse|June 28, 2005
[Is there a treatment for Alzheimer's disease?]S Joray, J Ghika, A von Gunten, et al.
Acta Neurochirurgica|February 14, 2004
Magnetic resonance artifact induced by the electrode Activa 3389: an in vitro and in vivo studyC Pollo, J-G Villemure, F Vingerhoets, et al.
Journal of Neurosurgery|November 17, 1998
Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up reviewJ Ghika, J G Villemure, H Fankhauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Acute reversible myoclonic encephalopathy associated with fluoxetine therapyF Ghika-Schmid, J Ghika, P Vuadens, et al.
Neurology|February 13, 2002
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-upFrançois J G Vingerhoets, J-G Villemure, P Temperli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 1997
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
IEEE Transactions on Bio-Medical Engineering|March 1, 1993
Portable system for quantifying motor abnormalities in Parkinson's diseaseJ Ghika, A W Wiegner, J J Fang, et al.
Neurology|December 15, 2004
Suicide after successful deep brain stimulation for movement disordersP R Burkhard, F J G Vingerhoets, A Berney, et al.
Neurology|May 20, 1998
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1995
Vascular ataxic hemiparesis: a re-evaluationT Moulin, J Bogousslavsky, J L Chopard, et al.
Pageof 8